Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists-Reference-Cited by-同舟云学术

Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists

Published:2012-02-08 Issue:3 Volume:3 Page:222-226
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Hu Shuanghua¹,Huang Yazhong¹,Deshpande Milind¹,Luo Guanglin¹,Bruce Marc A.¹,Chen Ling¹,Mattson Gail¹,Iben Lawrence G.¹,Zhang Jie¹,Russell John W.¹,Clarke Wendy J.¹,Hogan John B.¹,Ortiz Astrid¹,Flint Oliver¹,Henwood Andrew¹,Gao Qi¹,Antal-Zimanyi Ildiko¹,Poindexter Graham S.¹

Affiliation:

1. Research & Development, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml200265m

Reference33 articles.

1. NPY receptors as potential targets for anti-obesity drug development

2. Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development

3. NPY-Ergic agents for the treatment of obesity

4. Modulation of neuropeptide Y receptors for the treatment of obesity

5. Neuropeptide Y receptors as targets of obesity treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transition-Metal-Free Synthesis of Tertiary Aminocyclopropanes;Organic Letters;2016-12-01

2. Recent Developments in the Stereocontrolled Synthesis of Highly Substituted Cyclopentane Core Structures: From Drug Discovery Research to Natural Product Synthesis;Current Organic Chemistry;2014-04

3. Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist;Bioorganic & Medicinal Chemistry Letters;2013-07